Despite the Use of the Combination of G-CSF and Plerixafor for Stem Cell Mobilization, One Third of the Patients with Lymphoma Were Still “Poor Mobilizer” Using the Criteria Recently Proposed by GITMO (< 2.0 X 10 6 CD 34 + Cells Per Kg in ≤ 3 Apheresis)

H.C Fung; J Tornatta; B McLeod; S Nathan; J Maciejewski; E Rich; R Karmali; A Jimenez; K.W Christopherson; S.A Gregory

doi:10.1016/j.bbmt.2011.12.175

Back

Despite the Use of the Combination of G-CSF and Plerixafor for Stem Cell Mobilization, One Third of the Patients with Lymphoma Were Still “Poor Mobilizer” Using the Criteria Recently Proposed by GITMO (< 2.0 X 10 6 CD 34 + Cells Per Kg in ≤ 3 Apheresis)

Journal article

Open access

Peer reviewed

Despite the Use of the Combination of G-CSF and Plerixafor for Stem Cell Mobilization, One Third of the Patients with Lymphoma Were Still “Poor Mobilizer” Using the Criteria Recently Proposed by GITMO (< 2.0 X 10 6 CD 34 + Cells Per Kg in ≤ 3 Apheresis)

H.C Fung, J Tornatta, B McLeod, S Nathan, J Maciejewski, E Rich, R Karmali, A Jimenez, K.W Christopherson and S.A Gregory

Biology of blood and marrow transplantation, Vol.18(2), pp.S263-S263

2012

DOI: https://doi.org/10.1016/j.bbmt.2011.12.175

Files and links (1)

url

https://doi.org/10.1016/j.bbmt.2011.12.175View

Published (Version of record) Open

Metrics

5 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Despite the Use of the Combination of G-CSF and Plerixafor for Stem Cell Mobilization, One Third of the Patients with Lymphoma Were Still “Poor Mobilizer” Using the Criteria Recently Proposed by GITMO (< 2.0 X 10 6 CD 34 + Cells Per Kg in ≤ 3 Apheresis)
Creators: H.C Fung - Coleman Foundation Blood and Marrow Transpalnt Center, Rush Cancer Center and Rush University Medical Center, Chicago, IL
J Tornatta - Coleman Foundation Blood and Marrow Transpalnt Center, Rush Cancer Center and Rush University Medical Center, Chicago, IL
B McLeod - Coleman Foundation Blood and Marrow Transpalnt Center, Rush Cancer Center and Rush University Medical Center, Chicago, IL
S Nathan - Coleman Foundation Blood and Marrow Transpalnt Center, Rush Cancer Center and Rush University Medical Center, Chicago, IL
J Maciejewski - Coleman Foundation Blood and Marrow Transpalnt Center, Rush Cancer Center and Rush University Medical Center, Chicago, IL
E Rich - Coleman Foundation Blood and Marrow Transpalnt Center, Rush Cancer Center and Rush University Medical Center, Chicago, IL
R Karmali - Coleman Foundation Blood and Marrow Transpalnt Center, Rush Cancer Center and Rush University Medical Center, Chicago, IL
A Jimenez - Coleman Foundation Blood and Marrow Transpalnt Center, Rush Cancer Center and Rush University Medical Center, Chicago, IL
K.W Christopherson - Coleman Foundation Blood and Marrow Transpalnt Center, Rush Cancer Center and Rush University Medical Center, Chicago, IL
S.A Gregory - Rush University Medical Center, Chicago, IL
Publication Details: Biology of blood and marrow transplantation, Vol.18(2), pp.S263-S263
Publisher: Elsevier Inc
Language: English
Resource Type: Journal article
Record Identifier: 991031598027902976